Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-01624-0001-0000-6 |
Chemical Name: | Alloxan monohydrate |
CASRN: | 3237-50-1 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 360113_SCE |
Study Result: | Positive |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Negative |
Induced Rat Liver S9 | 1_S9 | Weakly Positive |
Induced Rat Liver S9 | 2_S9 | Weakly Positive |
Induced Rat Liver S9 | 3_S9 | Positive |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1049 | 448 | 0.427 | 8.96 | 26.5 | 0.000 |
Test Chemical | Alloxan monohydrate | 89.7 | 50 | 1047 | 466 | 0.445 | 9.32 | 26.5 | 4.217 |
299 | 50 | 1041 | 460 | 0.442 | 9.20 | 26.5 | 3.468 | ||
897 | 50 | 1051 | 468 | 0.445 | 9.36 | 26.5 | 4.265 | ||
Positive Control | Mitomycin-C | 0.002 | 50 | 1048 | 800 | 0.763 | 16.00 | 26.5 | 78.742 |
Mitomycin-C | 0.01 | 10 | 211 | 333 | 1.578 | 33.30 | 26.5 | 269.538 | |
Trend: | 0.561 | ||||||||
Probability: | 0.287 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1041 | 499 | 0.479 | 9.98 | 26.0 | 0.000 |
Test Chemical | Alloxan monohydrate | 299 | 50 | 1047 | 520 | 0.497 | 10.40 | 26.0 | 3.611 |
897 | 50 | 1048 | 582 | 0.555 | 11.64 | 26.0 | 15.854 | ||
2990 | 50 | 1045 | 715 | 0.684 | 14.30 | 26.0 | 42.738 | ||
Positive Control | Cyclophosphamide | 0.5 | 50 | 1047 | 751 | 0.717 | 15.02 | 26.0 | 49.639 |
Cyclophosphamide | 2.5 | 10 | 209 | 341 | 1.632 | 34.10 | 26.0 | 240.375 | |
Trend: | 6.564 | ||||||||
Probability: | 0.000 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1050 | 451 | 0.430 | 9.02 | 25.5 | 0.000 |
Test Chemical | Alloxan monohydrate | 2000 | 50 | 1051 | 509 | 0.484 | 10.18 | 25.5 | 12.753 |
2500 | 50 | 1048 | 552 | 0.527 | 11.04 | 25.5 | 22.628 | ||
3000 | 50 | 1050 | 537 | 0.511 | 10.74 | 25.5 | 19.069 | ||
Positive Control | Cyclophosphamide | 0.5 | 50 | 1043 | 873 | 0.837 | 17.46 | 25.5 | 94.869 |
Cyclophosphamide | 2.5 | 10 | 211 | 412 | 1.953 | 41.20 | 25.5 | 354.598 | |
Trend: | 3.036 | ||||||||
Probability: | 0.001 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1046 | 394 | 0.377 | 7.88 | 25.5 | 0.000 |
Test Chemical | Alloxan monohydrate | 1990 | 50 | 1042 | 430 | 0.413 | 8.60 | 25.5 | 9.556 |
2490 | 50 | 1047 | 475 | 0.454 | 9.50 | 25.5 | 20.443 | ||
2990 | 50 | 1048 | 504 | 0.481 | 10.08 | 25.5 | 27.675 | ||
Positive Control | Cyclophosphamide | 0.5 | 50 | 1045 | 567 | 0.543 | 11.34 | 25.5 | 44.046 |
Cyclophosphamide | 2.5 | 10 | 209 | 284 | 1.359 | 28.40 | 25.5 | 260.751 | |
Trend: | 3.906 | ||||||||
Probability: | 0.000 |